Citation only
via OpenAlex
Pharmacotherapy of age-related macular degeneration
Moloud Ahmadi, Jennifer I. Lim
Expert Opinion on Pharmacotherapy · 2008 · ▲ 18 citations
Abstract
BACKGROUND: Age-related macular degeneration is the leading cause of blindness in the developed world. The number of persons with vision loss from age-related macular degeneration is projected to increase dramatically over the next few decades. Therefore, effective therapeutic and prophylactic agents are greatly needed. OBJECTIVE: This article will discuss some of the newer treatment strategies that may help to reduce the incidence of visual loss from age-related macular degeneration. Some of these therapies and strategies can be implemented today, while many are hypothetical based on current laboratory data and ongoing clinical trials. METHODS: A review of the literature and ongoing clinical trials was undertaken. CONCLUSION: Current therapies using antioxidants for prevention of the progression of age-related macular degeneration and anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration have given us tools for tackling this disease better and reducing the number of patients with vision loss. Combinations of some of the existing treatments and new forms of therapy may yet further decrease the treatment burden in the future.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1517/14656560802473480
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Ahmadi, M., & Lim, J.I. (2008). Pharmacotherapy of age-related macular degeneration. <em>Expert Opinion on Pharmacotherapy</em>. https://doi.org/10.1517/14656560802473480
Vancouver
Ahmadi M, Lim JI. Pharmacotherapy of age-related macular degeneration. Expert Opinion on Pharmacotherapy. 2008. doi:10.1517/14656560802473480.
BibTeX
@article{moloud2008Pharma,
title = {Pharmacotherapy of age-related macular degeneration},
author = {Moloud Ahmadi and Jennifer I. Lim},
journal = {Expert Opinion on Pharmacotherapy},
year = {2008},
doi = {10.1517/14656560802473480},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pharmaceutics 2021
Open access · CC-BY
Nanotechnology for Age-Related Macular Degeneration
International Ophthalmology Clinics 2004
Citation only
The Epidemiology of Age-Related Macular Degeneration
Springer eBooks 2005
Citation only
Epidemiology of Age-Related Macular Degeneration
American Journal of Ophthalmology 2004
Citation only
The epidemiology of age-related macular degeneration
Nature reviews. Immunology 2013
Preprint · OA
Immunology of age-related macular degeneration
Advances in experimental medicine and biology 2021
Preprint · OA